期刊文献+

肾透明细胞癌VHL基因突变与CyclinD1过度表达的相关性 被引量:7

Correlation of Cyclin D1 Overexpression to Mutations of von Hippel-Lindau Gene in Renal Clear Cell Carcinoma
暂未订购
导出
摘要 背景与目的:VHL基因突变与肾透明细胞癌发生关系密切,而CyclinD1基因通过促进细胞过度增殖,对肾透明细胞癌发生和发展起重要作用。本研究拟初步探讨肾透明细胞癌中VHL基因突变的状况及其与CyclinD1表达上升的相关性。方法:取50例肾透明细胞癌手术标本,抽提病变组织和癌周正常组织中的基因组DNA和总RNA。通过PCR扩增VHL基因各外显子序列并测序以及内切酶鉴定的方法,确定肿瘤组织中VHL基因突变的比率和具体位点。通过RT-PCR和Westernblot方法,检测相应肿瘤组织中CyclinD1的表达水平是否发生改变。结果:VHL基因序列检测结果表明,有42例(84.0%)肾透明细胞癌标本的VHL基因发生各种形式的突变,有12(24.0%)例甚至发生2种以上的基因突变。在57例VHL基因外显子突变中,1号外显子突变有17例(29.8%);2号外显子突变有26例(45.6%);3号外显子突变有14例(24.6%)。CyclinD1的表达水平在42例VHL基因发生突变的组织中均有不同程度的上升,达到正常对照组的2~10倍(3.91±1.54倍)(P<0.01),另8例表现为正常。结论:在肾透明细胞癌中存在各种VHL基因突变,导致CyclinD1过度表达。 BACKGROUND & OBJECTIVE. The mutation of von Hippel- Lindau (VHL) tumor suppressor gene is closely related with tumorigenesis of renal clear cell carcinoma (RCCC). Cyclin D1 gene plays an important role in progression of RCCC by stimulating cell proliferation. This study was to determine the mutation of VHL gene in RCCC, and explore its correlation to overexpression of Cyclin D1. METHODS: The specimens of RCCC and adjacent normal renal tissue from 50 patients were collected after surgery. Total RNA and genomic DNA were extracted from each sample. Variant exons in VHL gene were amplified by polymerase chain reaction (PCR) and sequenced, and DNA hypermethylation was detected by restriction analysis. Reverse transcription-PCR (RT-PCR) and Western blot were used to detect the expression of Cyclin D1. RESULTS. Of the 50 specimens, 42 (84.0%) had various VHL gene mutations, 12 (24.0%) had more than 1 kind of gene mutation. Of the 57 cases of exon mutation of VHL gene, 17 (29.8%) were located in exon 1, 26 (45.6%) in exon 2, and 14 (24.6%) in exon 3. The expression of Cyclin D1 in the 42 cases with VHL gene mutation was increased to 2-10 (3.91±1.54) times that of normal controls (P〈0.01). Cyclin D1 expression in the other 8 cases was normal. CONCLUSION: There are variant mutations of VHL gene in RCCC, which may lead to overexpression of Cyclin D1.
出处 《癌症》 SCIE CAS CSCD 北大核心 2006年第2期175-178,共4页 Chinese Journal of Cancer
关键词 肾肿瘤 肾透明细胞 VHL基因 细胞周期素D1 基因突变 Renal neoplasms Carcinoma, renal clear cell VHL gene Cyclin D1 Gene mutation
  • 相关文献

参考文献11

  • 1Latif F, Tory K, Brauch H, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene [J]. Science,1993,260(5112) : 1317-1320.
  • 2Kaelin W G Jr. The yon Hippel-Lindau tumor suppressor gene and kidney cancer [J]. Clin Cancer Res, 2004,10( 18 Pt 2):6290S-6295S.
  • 3田玉楼,刘芙蓉,刘洁,姜莉,罗阳,张学.Cyclin G2抑制肿瘤细胞增殖的研究[J].癌症,2002,21(6):577-581. 被引量:17
  • 4Herman J G, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma[J]. Proc Natl Acad Sci USA, 1994,91 (21) :9700-9704.
  • 5Kondo K, Yao M, Yoshida M, et al. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters [J].Genes Chromosomes Cancer, 2002,34 ( 1 ) : 58-68.
  • 6Li Z, Na X, Wang D, et al. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to yon HippelLindau tumor suppressor protein [J]. J Biol Chem, 2002,277( 7 ) : 4656-4662.
  • 7Yan Q, Kamura T, Cai Y, et al. Identification of Elongin C and Skpl sequences that determine Cullin selection [J]. J Biol Chem, 2004,279(41) :43019-43026.
  • 8Ashida S, Nishimori I, Tanimura M, et al. Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma [J]. J Cancer Res Clin Oncol, 2002,128(10):561-568.
  • 9Rathmell W K, Hickey M M, Bezman N A, et al. In vitro and in vivo models analyzing yon Hippel-Lindau disease-specific mutations [J ]. Cancer Res, 2004,64 ( 23 ) : 8595-8603.
  • 10Kim W, Kaelin W G Jr. The yon Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer [ J ]. Curt Opin Genet Dev, 2003.13 ( 1 ):55-60.

二级参考文献10

  • 1吕有勇,高崇峰,崔建涛,孙梅程,金泉.胃癌中MTS1/p16基因缺失及表达异常的研究[J].中华肿瘤杂志,1996,18(3):189-191. 被引量:88
  • 2奥斯伯F 金斯顿RE.精编分子生物学实验指南[M].北京:科学出版社,1998.29-108.
  • 3Morsaki T, Uchiyama A, Yuzuki D, et al. Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cells [J]. Cancer Res, 1994,54(4):1113-1118.
  • 4Bartkova J, Lukas J, Muller H, et al. Cyclin D1 protein expression and function in human breast cancer [J]. Int J Cancer, 1994,57 (3) : 353-361.
  • 5Akama Y, Yasui WI,Kuniyas HI, et al. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines [J]. Jpn J Cancer Res, 1996,87(8) :824-830.
  • 6Igaki H, Sasaki H, Kishi T, et al. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines [J].Biochem Biophys Res Commun, 1994,203(2) : 1090-1095.
  • 7Shiohara M, E1-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies [J]. Blood,1994,84( 11 ) :3781-3784.
  • 8Slebos R J, Baas IO, Clement M, et al. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21^WAF1/Cip1 in colorectal carcinoma[J]. Br J Cancer, 1996,74(2):165-171.
  • 9Noda H, Maehara Y, Irie K, et al. Growth pattern and expressions of cell cycle regulator proteins p53 and p21^WAF1/CIP1 in early gastric carcinoma [J]. Cancer, 2001,92(7):1828-1835.
  • 10Liu XP, Tsushimi K, Tsushimi M, et al. Expression of P21^^WAF1/CIP1 and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis [J].Cancer Lett, 2001,170(2) : 183-189.

共引文献25

同被引文献49

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部